Stefan Bourgeois

Sustained virologic response of 100% in HCV genotype 1b patients with cirrhosis receiving ombitasvir/paritaprevir/r and dasabuvir for 12 weeks

Jordan J. Feld, Christophe Moreno, Roger Trinh et al. · Journal of Hepatology · 2015 · 160 citations · Full text

Efficacy of the Long-Acting Repeatable Formulation of the Somatostatin Analogue Octreotide in Postoperative Dumping

Joris Arts, Philip Caenepeel, Raf Bisschops et al. · Clinical Gastroenterology and Hepatology · 2008 · 138 citations

Medicine, Somatostatin Analogue Octreotide, Long-acting Repeatable Formulation +3

JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic Infection

Fabien Zoulim, Oliver Lenz, Joris Vandenbossche et al. · Gastroenterology · 2020 · 114 citations · Full text

Efficacy and safety of simeprevir with PegIFN/ribavirin in naïve or experienced patients infected with chronic HCV genotype 4

Christophe Moreno, Christophe Hézode, Patrick Marcellin et al. · Journal of Hepatology · 2015 · 81 citations

Experienced Patients, Hepatitis C, Viral Hepatitis +8

Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial

Man‐Fung Yuen, Tarik Asselah, Ira M. Jacobson et al. · ˜The œLancet. Gastroenterology & hepatology · 2023 · 64 citations

Ide Analogues, Viral Hepatitis, Medicine +10